Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Saltsjöbaden – page 13

771 clinical trials in Saltsjöbaden, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Saltsjöbaden at a glance
771
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

771 trials in Saltsjöbaden

Open in trial search

Acromegaly

Recruiting

Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Lanreotide
  • Sponsor:Debiopharm International S.A.

Neoplasm

Recruiting

Study of BMS-986482 alone or with nivolumab, relatlimab or bevacizumab in patients with advanced solid tumors

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of personalized tamoxifen dosing (10mg, 20mg, or 40mg daily) compared to standard dose (20mg) in women with breast cancer to improve treatment continuation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tamoxifen
  • Sponsor:Karolinska Institutet

Hypertension

Recruiting

Evaluating Citrulline, Folic Acid, Vericiguat, and Tadalafil Combination for Patients with Treatment-Resistant High Blood Pressure

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Folic Acid
  • Sponsor:Karolinska University Hospital

Study on the Effectiveness and Safety of Infigratinib for Children with Hypochondroplasia and Short Stature

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Infigratinib
  • Sponsor:Qed Therapeutics Inc.

Neuroblastoma

Recruiting

Study of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Bevacizumab
  • Sponsor:The University Of Birmingham

Phenylketonuria

Recruiting

Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Sepiapterin
  • Sponsor:PTC Therapeutics Inc.

Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study of intraperitoneal chemotherapy (PIPAC) with cisplatin and doxorubicin combined with minimally invasive surgery in patients with high-risk gastric cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Odense University Hospital

Prostate cancer

Recruiting

Study on Darolutamide for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Modified Vaccinia Ankara – Bavarian Nordic Live Virus
  • Sponsor:The Public Health Agency Of Sweden

Study on Acupuncture and Metformin for Improving Insulin Sensitivity in Women with Polycystic Ovary Syndrome

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Metformin Hydrochloride
  • Sponsor:Karolinska Institutet

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Saltsjöbaden

What the registry says about research in the country

01 Diseases [C] - Virus Diseases [C02]

In Saltsjöbaden, clinical research in this area focuses on RSV infection and the immune response to prevention-focused interventions. These studies are looking at how well a new approach can support protection against respiratory viral illness in older adults.

  • RSV infection
  • Respiratory tract diseases
  • Evaluating immune protection against viral infection

The work is centered on understanding whether the intervention can strengthen the body’s defense against RSV and help reduce the impact of this common respiratory virus.

02 Diseases [C] - Respiratory Tract Diseases [C08]

This research field covers trials aimed at preventing or reducing illness related to respiratory tract diseases, with a strong focus on RSV infection. The main goal is to assess how effective a vaccine-based strategy may be in older adults.

  • Respiratory tract disease prevention
  • RSV antibody response
  • Testing a new preventive therapy

These studies help clarify whether the intervention can improve protection in populations more vulnerable to severe respiratory infections.

03 Diseases [C] - Bacterial Infections and Mycoses [C01]

Clinical trials in this therapeutic area are examining treatment options for Diabetic Foot Ulcer, a wound complication where infection control and healing are major concerns. The research is focused on finding better local antimicrobial care to support complete wound closure.

  • Diabetic Foot Ulcer
  • Bacterial infection management
  • Improving wound healing outcomes

In Sweden, this line of research is comparing approaches that may help clinicians choose more effective treatments for difficult-to-heal ulcers.

04 Diabetic Foot Ulcer

The trial activity around Diabetic Foot Ulcer is aimed at evaluating how well local antimicrobial agents help wounds heal. It is a practical, patient-centered area of research focused on treatment effectiveness and recovery.

  • Local antimicrobial treatment
  • Time to healing
  • Wound care and infection control

These studies are intended to improve everyday care for people living with chronic foot ulcers linked to diabetes.

05 RSV infection

Research on RSV infection is centered on prevention and immune response in older adults, especially those at higher risk of severe disease. The trials are assessing whether a new protective strategy can generate helpful neutralizing antibodies.

  • Older adult respiratory health
  • Immune response to RSV
  • Preventive vaccine research

This work supports better understanding of how to reduce the burden of RSV in aging populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.